Shankland named CMPMedica CEO

Share this article:
CMPMedica named Sally Shankland CEO of CMPMedica US, replacing Vicki Masseria.

Shankland was previously SVP of the firm's US promotional business unit, a role she served for six years. She has worked for CMPMedica owner United Business Media since 1988, when she joined Miller Freeman. She orchestrated the 2006 launch of SearchMedica. Harry Elkington, global CEO of CMPMedica, praised her “great track record in building the promotional side of our business.”
Masseria spent 26 years with CMPMedica and its predecessor companies. Through a CMPMedica spokesperson, she declined comment on her future plans.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.